Cervical cancer: A global health crisis
Cervical cancer is the fourth most common malignancy diagnosed in women worldwide. Nearly all cases of cervical cancer result from infection with the human papillomavirus, and the prevention of cervical cancer includes screening and vaccination. Primary treatment options for patients with cervical c...
Gespeichert in:
| Veröffentlicht in: | Cancer Jg. 123; H. 13; S. 2404 - 2412 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
Wiley Subscription Services, Inc
01.07.2017
|
| Schlagworte: | |
| ISSN: | 0008-543X, 1097-0142, 1097-0142 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Cervical cancer is the fourth most common malignancy diagnosed in women worldwide. Nearly all cases of cervical cancer result from infection with the human papillomavirus, and the prevention of cervical cancer includes screening and vaccination. Primary treatment options for patients with cervical cancer may include surgery or a concurrent chemoradiotherapy regimen consisting of cisplatin‐based chemotherapy with external beam radiotherapy and brachytherapy. Cervical cancer causes more than one quarter of a million deaths per year as a result of grossly deficient treatments in many developing countries. This warrants a concerted global effort to counter the shocking loss of life and suffering that largely goes unreported. This article provides a review of the biology, prevention, and treatment of cervical cancer, and discusses the global cervical cancer crisis and efforts to improve the prevention and treatment of the disease in underdeveloped countries. Cancer 2017;123:2404–12. © 2017 American Cancer Society.
Cervical cancer is a leading cause of death worldwide. In this article, the authors discuss the biology, prevention, and treatment of this disease, in addition to activist efforts aimed at improving treatment and access to care. |
|---|---|
| AbstractList | Cervical cancer is the fourth most common malignancy diagnosed in women worldwide. Nearly all cases of cervical cancer result from infection with the human papillomavirus, and the prevention of cervical cancer includes screening and vaccination. Primary treatment options for patients with cervical cancer may include surgery or a concurrent chemoradiotherapy regimen consisting of cisplatin-based chemotherapy with external beam radiotherapy and brachytherapy. Cervical cancer causes more than one quarter of a million deaths per year as a result of grossly deficient treatments in many developing countries. This warrants a concerted global effort to counter the shocking loss of life and suffering that largely goes unreported. This article provides a review of the biology, prevention, and treatment of cervical cancer, and discusses the global cervical cancer crisis and efforts to improve the prevention and treatment of the disease in underdeveloped countries. Cancer 2017;123:2404-12. © 2017 American Cancer Society. Cervical cancer is the fourth most common malignancy diagnosed in women worldwide. Nearly all cases of cervical cancer result from infection with the human papillomavirus, and the prevention of cervical cancer includes screening and vaccination. Primary treatment options for patients with cervical cancer may include surgery or a concurrent chemoradiotherapy regimen consisting of cisplatin-based chemotherapy with external beam radiotherapy and brachytherapy. Cervical cancer causes more than one quarter of a million deaths per year as a result of grossly deficient treatments in many developing countries. This warrants a concerted global effort to counter the shocking loss of life and suffering that largely goes unreported. This article provides a review of the biology, prevention, and treatment of cervical cancer, and discusses the global cervical cancer crisis and efforts to improve the prevention and treatment of the disease in underdeveloped countries. Cancer 2017;123:2404-12. © 2017 American Cancer Society. Cervical cancer is a leading cause of death worldwide. In this article, the authors discuss the biology, prevention, and treatment of this disease, in addition to activist efforts aimed at improving treatment and access to care. Cervical cancer is the fourth most common malignancy diagnosed in women worldwide. Nearly all cases of cervical cancer result from infection with the human papillomavirus, and the prevention of cervical cancer includes screening and vaccination. Primary treatment options for patients with cervical cancer may include surgery or a concurrent chemoradiotherapy regimen consisting of cisplatin‐based chemotherapy with external beam radiotherapy and brachytherapy. Cervical cancer causes more than one quarter of a million deaths per year as a result of grossly deficient treatments in many developing countries. This warrants a concerted global effort to counter the shocking loss of life and suffering that largely goes unreported. This article provides a review of the biology, prevention, and treatment of cervical cancer, and discusses the global cervical cancer crisis and efforts to improve the prevention and treatment of the disease in underdeveloped countries. Cancer 2017;123:2404–12. © 2017 American Cancer Society . Cervical cancer is a leading cause of death worldwide. In this article, the authors discuss the biology, prevention, and treatment of this disease, in addition to activist efforts aimed at improving treatment and access to care. Cervical cancer is the fourth most common malignancy diagnosed in women worldwide. Nearly all cases of cervical cancer result from infection with the human papillomavirus, and the prevention of cervical cancer includes screening and vaccination. Primary treatment options for patients with cervical cancer may include surgery or a concurrent chemoradiotherapy regimen consisting of cisplatin-based chemotherapy with external beam radiotherapy and brachytherapy. Cervical cancer causes more than one quarter of a million deaths per year as a result of grossly deficient treatments in many developing countries. This warrants a concerted global effort to counter the shocking loss of life and suffering that largely goes unreported. This article provides a review of the biology, prevention, and treatment of cervical cancer, and discusses the global cervical cancer crisis and efforts to improve the prevention and treatment of the disease in underdeveloped countries. Cancer 2017;123:2404-12. © 2017 American Cancer Society.Cervical cancer is the fourth most common malignancy diagnosed in women worldwide. Nearly all cases of cervical cancer result from infection with the human papillomavirus, and the prevention of cervical cancer includes screening and vaccination. Primary treatment options for patients with cervical cancer may include surgery or a concurrent chemoradiotherapy regimen consisting of cisplatin-based chemotherapy with external beam radiotherapy and brachytherapy. Cervical cancer causes more than one quarter of a million deaths per year as a result of grossly deficient treatments in many developing countries. This warrants a concerted global effort to counter the shocking loss of life and suffering that largely goes unreported. This article provides a review of the biology, prevention, and treatment of cervical cancer, and discusses the global cervical cancer crisis and efforts to improve the prevention and treatment of the disease in underdeveloped countries. Cancer 2017;123:2404-12. © 2017 American Cancer Society. |
| Author | Chuang, Linus T. Kitchener, Henry C. Harkenrider, Matthew M. Bajaj, Amishi Jhingran, Anuja Viswanathan, Akila N. Small, William Gaffney, David K. Fisher, Brandon J. Mileshkin, Linda R. Bacon, Monica A. |
| Author_xml | – sequence: 1 givenname: William orcidid: 0000-0002-1623-9863 surname: Small fullname: Small, William email: wmsmall@lumc.edu organization: Stritch School of Medicine, Loyola University – sequence: 2 givenname: Monica A. surname: Bacon fullname: Bacon, Monica A. organization: Gynecological Cancer InterGroup – sequence: 3 givenname: Amishi surname: Bajaj fullname: Bajaj, Amishi organization: Stritch School of Medicine, Loyola University – sequence: 4 givenname: Linus T. surname: Chuang fullname: Chuang, Linus T. organization: Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai – sequence: 5 givenname: Brandon J. surname: Fisher fullname: Fisher, Brandon J. organization: Gamma West Cancer Services – sequence: 6 givenname: Matthew M. surname: Harkenrider fullname: Harkenrider, Matthew M. organization: Stritch School of Medicine, Loyola University – sequence: 7 givenname: Anuja surname: Jhingran fullname: Jhingran, Anuja organization: The University of Texas MD Anderson Cancer Center – sequence: 8 givenname: Henry C. surname: Kitchener fullname: Kitchener, Henry C. organization: University of Manchester – sequence: 9 givenname: Linda R. surname: Mileshkin fullname: Mileshkin, Linda R. organization: Peter MacCallum Cancer Centre – sequence: 10 givenname: Akila N. surname: Viswanathan fullname: Viswanathan, Akila N. organization: Johns Hopkins University School of Medicine – sequence: 11 givenname: David K. surname: Gaffney fullname: Gaffney, David K. organization: Huntsman Cancer Institute, University of Utah |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28464289$$D View this record in MEDLINE/PubMed |
| BookMark | eNp90MtKAzEUBuAgFXvRjQ8gAy4UYerJZWYSd2XwBkVBunAX0kxiU6YzNZkqfXuntt0UcRVO-P7D4e-jTlVXBqFzDEMMQG51pf2QQppmR6iHQWQxYEY6qAcAPE4Yfe-ifgjzdsxIQk9Ql3CWMsJFD13lxn85rcpIq0obfxeNoo-ynrYfM6PKZhZp74ILp-jYqjKYs907QJOH-0n-FI9fH5_z0TjWjNAstphjaxJBMOHKFsCUVgILYSllRSqm2KgiUxxDwYlVAIaSLAFtC26ZtZoO0PV27dLXnysTGrlwQZuyVJWpV0FiLpjAnDHa0ssDOq9XvmqPk1gQYCkhHFp1sVOr6cIUcundQvm13DfQAtgC7esQvLFSu0Y1rq4ar1wpMchNyXJTsvwtuY3cHET2W__EeIu_XWnW_0iZv-Rv28wPzimJ5Q |
| CitedBy_id | crossref_primary_10_1007_s40291_025_00790_w crossref_primary_10_2217_fon_2017_0474 crossref_primary_10_3389_fonc_2022_1049773 crossref_primary_10_1080_07853890_2024_2371008 crossref_primary_10_1016_S0140_6736_17_31607_0 crossref_primary_10_1038_s41598_021_90007_x crossref_primary_10_1016_j_bspc_2022_104398 crossref_primary_10_1111_cas_14119 crossref_primary_10_3389_fcimb_2022_926348 crossref_primary_10_1007_s12668_022_00961_7 crossref_primary_10_1186_s12885_021_08059_1 crossref_primary_10_1097_MD_0000000000013860 crossref_primary_10_1016_j_gore_2018_06_007 crossref_primary_10_1016_j_fitote_2024_106323 crossref_primary_10_1136_ijgc_2021_002470 crossref_primary_10_1590_0102_311xpt277521 crossref_primary_10_3389_fsurg_2022_823566 crossref_primary_10_24060_2076_3093_2024_14_1_60_68 crossref_primary_10_3390_ijms20194822 crossref_primary_10_3389_fgene_2021_779195 crossref_primary_10_3389_fonc_2020_01733 crossref_primary_10_1016_j_prp_2024_155488 crossref_primary_10_7748_phc_2021_e1742 crossref_primary_10_1007_s12325_018_0683_3 crossref_primary_10_1002_jcp_30134 crossref_primary_10_1097_MD_0000000000023892 crossref_primary_10_1002_mp_15175 crossref_primary_10_2147_CMAR_S302201 crossref_primary_10_3389_fonc_2023_1143691 crossref_primary_10_1002_slct_202404858 crossref_primary_10_3390_cancers13236102 crossref_primary_10_1097_MD_0000000000038807 crossref_primary_10_3389_fonc_2019_00742 crossref_primary_10_2188_jea_JE20200142 crossref_primary_10_1002_ijgo_15771 crossref_primary_10_1016_j_bcp_2021_114891 crossref_primary_10_1159_000526700 crossref_primary_10_1002_jmv_29282 crossref_primary_10_1007_s40203_025_00380_y crossref_primary_10_1111_jog_15751 crossref_primary_10_2174_1574893618666230428095114 crossref_primary_10_1002_cam4_70847 crossref_primary_10_1016_j_heliyon_2023_e17712 crossref_primary_10_1038_s41388_018_0339_4 crossref_primary_10_1038_s41419_022_05547_5 crossref_primary_10_1111_jog_15998 crossref_primary_10_1371_journal_pone_0261503 crossref_primary_10_1007_s00520_024_08762_2 crossref_primary_10_1016_j_ijbiomac_2018_12_235 crossref_primary_10_1002_ddr_21908 crossref_primary_10_1016_j_bbrc_2018_10_146 crossref_primary_10_1016_j_ejphar_2024_176754 crossref_primary_10_3390_biom14080954 crossref_primary_10_1007_s12672_022_00610_1 crossref_primary_10_1007_s10863_021_09908_1 crossref_primary_10_3389_fonc_2021_723193 crossref_primary_10_1186_s12935_025_03786_y crossref_primary_10_12968_hmed_2024_0156 crossref_primary_10_1002_jcb_27911 crossref_primary_10_1016_j_bpj_2024_05_014 crossref_primary_10_1016_j_jri_2020_103115 crossref_primary_10_3390_cells11132027 crossref_primary_10_1002_kjm2_12593 crossref_primary_10_1371_journal_pone_0316323 crossref_primary_10_1007_s00210_019_01772_6 crossref_primary_10_1016_j_ijnurstu_2020_103768 crossref_primary_10_3390_medicina58040507 crossref_primary_10_1007_s10528_023_10494_7 crossref_primary_10_1016_j_jrras_2023_100568 crossref_primary_10_1016_j_ygeno_2020_08_024 crossref_primary_10_3389_fpubh_2024_1433718 crossref_primary_10_3389_fcimb_2025_1627668 crossref_primary_10_1002_adfm_202309984 crossref_primary_10_1016_j_critrevonc_2020_103178 crossref_primary_10_1134_S1068162024010242 crossref_primary_10_1016_j_jogoh_2024_102757 crossref_primary_10_1080_1061186X_2025_2519599 crossref_primary_10_3390_cancers14092108 crossref_primary_10_1155_2021_4228241 crossref_primary_10_1186_s11671_020_03449_z crossref_primary_10_1016_j_lfs_2020_117558 crossref_primary_10_1186_s12885_025_13527_z crossref_primary_10_1016_j_critrevonc_2025_104673 crossref_primary_10_1016_j_radcr_2022_04_058 crossref_primary_10_1016_j_molstruc_2025_141569 crossref_primary_10_3389_fmed_2023_1161835 crossref_primary_10_3389_fonc_2019_00760 crossref_primary_10_1186_s12967_023_04623_4 crossref_primary_10_1002_cncr_33795 crossref_primary_10_1186_s12935_019_0852_8 crossref_primary_10_1177_03000605211019190 crossref_primary_10_1016_j_chembiol_2024_04_006 crossref_primary_10_1002_fsn3_2315 crossref_primary_10_3390_medicina59020358 crossref_primary_10_1016_j_ygyno_2022_05_010 crossref_primary_10_3389_fonc_2021_752974 crossref_primary_10_3390_diagnostics14010005 crossref_primary_10_1016_j_ygyno_2022_05_006 crossref_primary_10_1007_s10995_021_03352_8 crossref_primary_10_1007_s11302_024_10020_3 crossref_primary_10_1016_j_gore_2021_100874 crossref_primary_10_3389_fmed_2022_759928 crossref_primary_10_1097_COC_0000000000000617 crossref_primary_10_1016_j_carres_2020_107991 crossref_primary_10_1016_j_ejrad_2019_01_003 crossref_primary_10_1016_j_gore_2018_05_005 crossref_primary_10_1007_s12088_024_01320_8 crossref_primary_10_5306_wjco_v12_i10_845 crossref_primary_10_2147_IJGM_S546538 crossref_primary_10_1007_s13224_024_02017_0 crossref_primary_10_3389_fphar_2022_899208 crossref_primary_10_1080_10799893_2020_1836495 crossref_primary_10_3389_fcell_2024_1465729 crossref_primary_10_1007_s12672_025_02224_9 crossref_primary_10_1016_j_meegid_2020_104266 crossref_primary_10_1007_s13105_019_00681_9 crossref_primary_10_3390_genes13071254 crossref_primary_10_1002_cbdv_202200114 crossref_primary_10_1007_s13187_024_02405_0 crossref_primary_10_1016_j_intimp_2020_107131 crossref_primary_10_1038_s41598_018_30070_z crossref_primary_10_1186_s12014_023_09408_x crossref_primary_10_1002_iub_1680 crossref_primary_10_3389_fonc_2021_774558 crossref_primary_10_1016_j_pdpdt_2023_103340 crossref_primary_10_1038_s41392_022_01003_0 crossref_primary_10_1063_5_0240772 crossref_primary_10_1016_j_csbj_2019_02_001 crossref_primary_10_1097_MD_0000000000010530 crossref_primary_10_3389_fmolb_2023_1188027 crossref_primary_10_1080_21691401_2019_1628038 crossref_primary_10_1093_carcin_bgy163 crossref_primary_10_1007_s12672_025_02834_3 crossref_primary_10_7717_peerj_9234 crossref_primary_10_1016_j_currproblcancer_2018_06_003 crossref_primary_10_1016_j_ijbiomac_2023_129177 crossref_primary_10_1016_j_ygyno_2020_07_025 crossref_primary_10_1080_21655979_2021_1968250 crossref_primary_10_1007_s13237_025_00548_z crossref_primary_10_1186_s13048_021_00789_x crossref_primary_10_1016_j_canep_2020_101849 crossref_primary_10_3389_fcell_2023_1170059 crossref_primary_10_1016_j_sajb_2023_10_067 crossref_primary_10_1097_MS9_0000000000002513 crossref_primary_10_1371_journal_ppat_1007352 crossref_primary_10_1016_j_ejogrb_2021_11_013 crossref_primary_10_1186_s12885_020_6630_0 crossref_primary_10_4103_jcrt_JCRT_783_19 crossref_primary_10_3389_fphar_2022_1065793 crossref_primary_10_1186_s12967_024_05332_2 crossref_primary_10_1134_S0026893323030093 crossref_primary_10_1158_1078_0432_CCR_20_2833 crossref_primary_10_3389_fimmu_2025_1616715 crossref_primary_10_1007_s40944_022_00702_4 crossref_primary_10_1007_s43032_024_01695_5 crossref_primary_10_1016_j_slast_2025_100313 crossref_primary_10_1186_s12967_020_02553_z crossref_primary_10_1039_C9RA07039G crossref_primary_10_1002_jcb_28806 crossref_primary_10_1002_kjm2_12432 crossref_primary_10_31083_j_ceog4902054 crossref_primary_10_3389_fmolb_2022_872932 crossref_primary_10_1186_s13027_023_00488_w crossref_primary_10_3390_cancers12051301 crossref_primary_10_1016_j_intimp_2024_113625 crossref_primary_10_1016_j_omto_2019_04_007 crossref_primary_10_3390_vaccines10111919 crossref_primary_10_1097_MD_0000000000044673 crossref_primary_10_1016_j_compbiomed_2022_105638 crossref_primary_10_1186_s12885_024_12915_1 crossref_primary_10_1016_j_vaccine_2019_10_092 crossref_primary_10_2147_CMAR_S311242 crossref_primary_10_1016_j_seminoncol_2025_152352 crossref_primary_10_12677_acm_2025_1541231 crossref_primary_10_3389_fonc_2022_1011000 crossref_primary_10_3390_biom9090494 crossref_primary_10_7759_cureus_17468 crossref_primary_10_1002_cncr_33115 crossref_primary_10_1136_bmjopen_2021_055470 crossref_primary_10_1016_j_nexres_2025_100660 crossref_primary_10_1097_MD_0000000000019372 crossref_primary_10_3389_fonc_2021_634732 crossref_primary_10_3390_app11020823 crossref_primary_10_1007_s11101_024_09957_5 crossref_primary_10_1007_s00066_022_02007_z crossref_primary_10_1111_cas_15723 crossref_primary_10_12677_acm_2025_153780 crossref_primary_10_1371_journal_pone_0304396 crossref_primary_10_1016_j_tjog_2020_07_013 crossref_primary_10_3389_fcell_2021_642724 crossref_primary_10_3389_fgene_2020_533628 crossref_primary_10_1016_j_brachy_2022_07_010 crossref_primary_10_1016_j_ijleo_2020_164292 crossref_primary_10_1007_s12013_024_01318_5 crossref_primary_10_1007_s10147_019_01551_6 crossref_primary_10_1177_0284185119890086 crossref_primary_10_2147_IJN_S326089 crossref_primary_10_1038_s41598_019_49061_9 crossref_primary_10_1371_journal_pone_0311137 crossref_primary_10_1097_PAS_0000000000001042 crossref_primary_10_1038_s41417_020_00243_y crossref_primary_10_1186_s13027_025_00651_5 crossref_primary_10_3389_fsurg_2021_735944 crossref_primary_10_1016_j_asjsur_2020_03_022 crossref_primary_10_1186_s40001_023_01490_z crossref_primary_10_1080_01443615_2023_2181690 crossref_primary_10_3389_fimmu_2021_678318 crossref_primary_10_1007_s00347_022_01665_9 crossref_primary_10_1038_s41598_022_20858_5 crossref_primary_10_1016_j_asjsur_2022_11_120 crossref_primary_10_3892_ijo_2022_5453 crossref_primary_10_1016_j_pdpdt_2025_104749 crossref_primary_10_1371_journal_pone_0325424 crossref_primary_10_4081_hls_2024_12189 crossref_primary_10_1007_s13187_023_02280_1 crossref_primary_10_1080_14737159_2023_2173580 crossref_primary_10_1371_journal_pone_0193340 crossref_primary_10_3390_ijms23073968 crossref_primary_10_1186_s13027_024_00622_2 crossref_primary_10_3389_fpubh_2021_654454 crossref_primary_10_3390_cancers13225748 crossref_primary_10_1093_abt_tbz004 crossref_primary_10_1186_s12905_021_01428_9 crossref_primary_10_1038_s41598_024_64574_8 crossref_primary_10_1155_2023_1766080 crossref_primary_10_1002_cncr_33040 crossref_primary_10_1016_S0140_6736_18_32470_X crossref_primary_10_1186_s12935_020_01384_8 crossref_primary_10_1007_s12672_025_03425_y crossref_primary_10_3390_ijms22062831 crossref_primary_10_1186_s12905_021_01493_0 crossref_primary_10_1111_cas_15988 crossref_primary_10_3390_cancers11121927 crossref_primary_10_1002_adfm_201904969 crossref_primary_10_2147_IJN_S269986 crossref_primary_10_1007_s00192_022_05326_y crossref_primary_10_3390_ijms25168932 crossref_primary_10_1177_11769351221090921 crossref_primary_10_3390_medicina56050207 crossref_primary_10_3892_etm_2023_12186 crossref_primary_10_1002_ange_202104304 crossref_primary_10_1002_jmv_28480 crossref_primary_10_1016_j_heliyon_2024_e30220 crossref_primary_10_1111_phn_13390 crossref_primary_10_3389_fonc_2022_887773 crossref_primary_10_1177_1534735419861693 crossref_primary_10_1186_s12905_023_02345_9 crossref_primary_10_2217_bmm_2020_0140 crossref_primary_10_3390_molecules26237407 crossref_primary_10_1002_advs_202302705 crossref_primary_10_1002_tox_23793 crossref_primary_10_1186_s12885_019_5997_2 crossref_primary_10_1002_tox_23555 crossref_primary_10_1186_s12885_019_5558_8 crossref_primary_10_1007_s12010_024_04873_y crossref_primary_10_1186_s12885_023_10517_x crossref_primary_10_1186_s12935_020_01736_4 crossref_primary_10_2147_CMAR_S265336 crossref_primary_10_3389_fonc_2023_1252074 crossref_primary_10_4103_egjp_egjp_31_24 crossref_primary_10_1186_s12967_025_06470_x crossref_primary_10_1016_j_biopha_2024_117519 crossref_primary_10_29254_2077_4214_2023_3_170_457_465 crossref_primary_10_1038_s41598_023_45537_x crossref_primary_10_3390_antiox11020422 crossref_primary_10_1038_s41420_022_01049_7 crossref_primary_10_1080_15384101_2021_2020962 crossref_primary_10_1016_j_jddst_2022_103897 crossref_primary_10_1016_j_bmc_2020_115950 crossref_primary_10_3923_ijp_2021_300_307 crossref_primary_10_1007_s13205_021_02926_1 crossref_primary_10_3389_fgene_2019_00125 crossref_primary_10_3390_cancers14122913 crossref_primary_10_1007_s00404_022_06824_6 crossref_primary_10_1186_s12967_021_02872_9 crossref_primary_10_1200_GO_20_00302 crossref_primary_10_2147_IJWH_S365236 crossref_primary_10_2196_58873 crossref_primary_10_1016_j_jep_2021_114345 crossref_primary_10_1186_s12967_024_05774_8 crossref_primary_10_3389_fonc_2021_784525 crossref_primary_10_1007_s00404_018_4740_6 crossref_primary_10_3389_fcimb_2024_1357090 crossref_primary_10_1080_14737140_2022_2047936 crossref_primary_10_3390_md18070375 crossref_primary_10_1097_NCC_0000000000001146 crossref_primary_10_3389_fonc_2021_619384 crossref_primary_10_3389_fcimb_2022_916506 crossref_primary_10_3892_ol_2018_9363 crossref_primary_10_1088_2043_6262_ac389c crossref_primary_10_1186_s12905_021_01419_w crossref_primary_10_1002_smll_202303772 crossref_primary_10_1111_imm_13056 crossref_primary_10_1016_j_compbiomed_2025_111116 crossref_primary_10_1002_agm2_12366 crossref_primary_10_2147_OTT_S282790 crossref_primary_10_1002_prca_202100105 crossref_primary_10_1016_j_lfs_2020_118190 crossref_primary_10_1002_jcp_31267 crossref_primary_10_1016_j_modpat_2023_100316 crossref_primary_10_1016_j_prp_2025_156116 crossref_primary_10_1186_s13014_024_02454_1 crossref_primary_10_1080_15384101_2021_1991106 crossref_primary_10_1186_s40001_024_01897_2 crossref_primary_10_3390_v15102015 crossref_primary_10_1016_j_bspc_2021_103373 crossref_primary_10_1016_j_jep_2024_118491 crossref_primary_10_3892_ol_2021_12878 crossref_primary_10_1002_cbin_11272 crossref_primary_10_3390_molecules24081580 crossref_primary_10_1016_j_tice_2022_101843 crossref_primary_10_3390_ijms22073774 crossref_primary_10_1002_hpm_3665 crossref_primary_10_2147_CMAR_S253174 crossref_primary_10_1097_MD_0000000000021146 crossref_primary_10_1111_jog_70035 crossref_primary_10_1128_MCB_00363_20 crossref_primary_10_1002_jmv_29480 crossref_primary_10_1016_j_cellsig_2024_111115 crossref_primary_10_1111_1440_1681_13222 crossref_primary_10_1080_21655979_2022_2034705 crossref_primary_10_1097_COC_0000000000001092 crossref_primary_10_3390_molecules29184476 crossref_primary_10_3390_v14081764 crossref_primary_10_1016_j_prp_2018_12_026 crossref_primary_10_1038_s41419_022_05036_9 crossref_primary_10_1016_j_techfore_2020_120375 crossref_primary_10_1186_s12935_021_02101_9 crossref_primary_10_1186_s12913_021_07176_8 crossref_primary_10_1111_jcmm_15414 crossref_primary_10_1186_s12967_021_02894_3 crossref_primary_10_1038_s41598_021_92875_9 crossref_primary_10_3389_fmolb_2023_1247536 crossref_primary_10_3390_md21050259 crossref_primary_10_1007_s12094_020_02409_4 crossref_primary_10_1128_MCB_00059_21 crossref_primary_10_1016_j_mri_2022_03_002 crossref_primary_10_1002_cam4_70394 crossref_primary_10_1016_j_ejphar_2022_174840 crossref_primary_10_1038_s41419_018_1059_y crossref_primary_10_2147_CMAR_S275172 crossref_primary_10_3390_cancers15235625 crossref_primary_10_1007_s00404_020_05559_6 crossref_primary_10_1089_cbr_2020_3865 crossref_primary_10_1016_j_repbio_2022_100644 crossref_primary_10_1007_s12247_021_09566_1 crossref_primary_10_1155_2020_9172908 crossref_primary_10_1186_s12860_022_00440_7 crossref_primary_10_3390_ijerph17238924 crossref_primary_10_3892_mmr_2020_11101 crossref_primary_10_1080_26410397_2021_2005283 crossref_primary_10_3389_fmolb_2021_763697 crossref_primary_10_31083_j_ceog4906144 crossref_primary_10_1177_0956462419825950 crossref_primary_10_1016_j_canlet_2024_216658 crossref_primary_10_3390_polym15102393 crossref_primary_10_1016_j_mpdhp_2020_02_007 crossref_primary_10_1111_jcmm_16996 crossref_primary_10_3802_jgo_2026_37_e20 crossref_primary_10_1016_j_phymed_2023_155088 crossref_primary_10_3390_medicina55070384 crossref_primary_10_4102_ajlm_v13i1_2374 crossref_primary_10_1111_cas_15780 crossref_primary_10_1111_cas_15664 crossref_primary_10_3389_fonc_2021_780387 crossref_primary_10_1136_jitc_2023_008355 crossref_primary_10_1007_s13577_021_00590_4 crossref_primary_10_1111_1750_3841_17137 crossref_primary_10_3389_fphar_2022_1065701 crossref_primary_10_1016_j_cej_2023_144177 crossref_primary_10_1155_2020_5135893 crossref_primary_10_2174_0118715265307980240826060516 crossref_primary_10_1016_j_tjog_2022_02_037 crossref_primary_10_1016_j_bmc_2021_115997 crossref_primary_10_1016_j_biopha_2021_111429 crossref_primary_10_1155_2021_6201634 crossref_primary_10_3390_mi12070764 crossref_primary_10_3389_fonc_2022_1049097 crossref_primary_10_1002_cam4_70296 crossref_primary_10_1097_MD_0000000000017301 crossref_primary_10_1097_CAD_0000000000001278 crossref_primary_10_2147_CMAR_S251582 crossref_primary_10_2174_0113816128286229240129090915 crossref_primary_10_5812_iranjradiol_86497 crossref_primary_10_1002_mc_23855 crossref_primary_10_1002_jcp_28731 crossref_primary_10_1007_s43032_025_01973_w crossref_primary_10_1097_LGT_0000000000000757 crossref_primary_10_3390_genes13030463 crossref_primary_10_1016_j_ejogrb_2020_05_039 crossref_primary_10_2217_epi_2019_0108 crossref_primary_10_1016_j_soncn_2019_02_003 crossref_primary_10_3390_ijms232315138 crossref_primary_10_1186_s13046_020_01793_7 crossref_primary_10_1016_j_jnutbio_2021_108899 crossref_primary_10_3390_ijms26062493 crossref_primary_10_1111_1745_5871_12281 crossref_primary_10_2217_nnm_2021_0044 crossref_primary_10_1016_j_heliyon_2023_e15096 crossref_primary_10_1186_s13063_021_05986_z crossref_primary_10_1002_anie_202423207 crossref_primary_10_1016_j_jddst_2022_103351 crossref_primary_10_1038_s41598_020_75173_8 crossref_primary_10_2147_CMAR_S242615 crossref_primary_10_2147_IJWH_S516444 crossref_primary_10_1042_BSR20181769 crossref_primary_10_1111_jcmm_16337 crossref_primary_10_1111_pin_12867 crossref_primary_10_1007_s00432_023_05267_z crossref_primary_10_1186_s12935_020_01476_5 crossref_primary_10_1186_s12905_023_02498_7 crossref_primary_10_21294_1814_4861_2025_24_2_117_125 crossref_primary_10_3389_fgene_2022_1061107 crossref_primary_10_1177_10732748221117900 crossref_primary_10_1186_s12905_023_02726_0 crossref_primary_10_1186_s12905_020_00972_0 crossref_primary_10_1007_s00330_020_06884_9 crossref_primary_10_1186_s12885_025_13454_z crossref_primary_10_1002_2211_5463_13298 crossref_primary_10_1007_s00335_025_10127_x crossref_primary_10_1186_s12935_019_1048_y crossref_primary_10_1016_j_gore_2017_08_004 crossref_primary_10_3389_fmolb_2020_00107 crossref_primary_10_1016_j_bcp_2023_115627 crossref_primary_10_3390_cancers11081193 crossref_primary_10_1186_s12905_025_03802_3 crossref_primary_10_1186_s13690_025_01629_w crossref_primary_10_1002_cbf_3526 crossref_primary_10_1088_1742_6596_1321_2_022087 crossref_primary_10_1002_mc_22782 crossref_primary_10_1371_journal_pone_0217201 crossref_primary_10_3389_fonc_2025_1614434 crossref_primary_10_1016_j_yexcr_2023_113621 crossref_primary_10_1002_cam4_3659 crossref_primary_10_7759_cureus_82524 crossref_primary_10_1016_j_brachy_2020_02_004 crossref_primary_10_1038_s41419_017_0149_6 crossref_primary_10_2147_OTT_S279951 crossref_primary_10_1002_jcb_27472 crossref_primary_10_1200_GO_21_00214 crossref_primary_10_1111_cbdd_14424 crossref_primary_10_1186_s13027_023_00504_z crossref_primary_10_2147_CMAR_S262215 crossref_primary_10_7759_cureus_57120 crossref_primary_10_1016_j_pedn_2017_12_003 crossref_primary_10_1111_jcmm_15573 crossref_primary_10_1016_j_cmi_2024_03_035 crossref_primary_10_1186_s12885_020_07441_9 crossref_primary_10_3390_molecules23092334 crossref_primary_10_2147_OTT_S279942 crossref_primary_10_1016_j_biomaterials_2022_121411 crossref_primary_10_4014_jmb_2010_10055 crossref_primary_10_1177_03008916251341993 crossref_primary_10_1016_j_pdpdt_2021_102394 crossref_primary_10_1016_j_phrs_2019_104616 crossref_primary_10_2147_CMAR_S327056 crossref_primary_10_3389_fimmu_2023_1118458 crossref_primary_10_1007_s11547_023_01632_7 crossref_primary_10_1016_j_ygyno_2023_09_004 crossref_primary_10_1016_j_ygyno_2023_02_001 crossref_primary_10_1038_s41598_022_20566_0 crossref_primary_10_1515_biol_2022_0819 crossref_primary_10_1002_slct_202304429 crossref_primary_10_1155_2020_5478574 crossref_primary_10_1016_j_prp_2020_152994 crossref_primary_10_1186_s13048_020_00668_x crossref_primary_10_1016_j_currproblcancer_2018_01_016 crossref_primary_10_1016_j_ajog_2018_12_011 crossref_primary_10_1177_0969141320984199 crossref_primary_10_1016_j_cej_2024_152295 crossref_primary_10_1111_aogs_13442 crossref_primary_10_1097_MD_0000000000038116 crossref_primary_10_1002_ijc_31297 crossref_primary_10_1136_bmjopen_2021_059593 crossref_primary_10_1038_s41467_025_57323_6 crossref_primary_10_1016_j_biopha_2019_108613 crossref_primary_10_1186_s12935_021_02239_6 crossref_primary_10_1186_s13104_023_06334_x crossref_primary_10_1007_s12672_025_02371_z crossref_primary_10_3892_ol_2025_15087 crossref_primary_10_1186_s12935_020_01387_5 crossref_primary_10_1186_s40644_020_00298_y crossref_primary_10_1016_j_bbrc_2022_09_091 crossref_primary_10_3390_medicina59030600 crossref_primary_10_1097_MD_0000000000031928 crossref_primary_10_1080_01443615_2023_2213328 crossref_primary_10_4103_ijc_IJC_538_19 crossref_primary_10_3390_molecules25081960 crossref_primary_10_1016_j_ijrobp_2022_04_027 crossref_primary_10_3389_fphar_2022_870221 crossref_primary_10_1007_s10876_020_01766_y crossref_primary_10_3390_ijms25158284 crossref_primary_10_1200_JGO_18_00074 crossref_primary_10_1109_JBHI_2022_3223127 crossref_primary_10_1007_s43032_021_00661_9 crossref_primary_10_1186_s12885_022_10142_0 crossref_primary_10_1038_s41420_024_01899_3 crossref_primary_10_1038_s41420_024_02259_x crossref_primary_10_1111_jog_16119 crossref_primary_10_1016_j_heliyon_2025_e41964 crossref_primary_10_1016_j_heliyon_2024_e39148 crossref_primary_10_1186_s12885_022_10188_0 crossref_primary_10_1371_journal_pone_0296015 crossref_primary_10_1155_2022_5025451 crossref_primary_10_1186_s12885_024_12658_z crossref_primary_10_3389_fchem_2021_672917 crossref_primary_10_7759_cureus_77389 crossref_primary_10_7759_cureus_78115 crossref_primary_10_1002_cam4_3601 crossref_primary_10_1089_jwh_2021_0447 crossref_primary_10_3390_ijms23137165 crossref_primary_10_1039_C9RA02482D crossref_primary_10_1016_j_lfs_2020_118902 crossref_primary_10_3389_fonc_2018_00113 crossref_primary_10_1002_pro6_1085 crossref_primary_10_1007_s00432_023_05399_2 crossref_primary_10_1002_jmv_28435 crossref_primary_10_1159_000520642 crossref_primary_10_1186_s13014_021_01978_0 crossref_primary_10_3389_fimmu_2022_993118 crossref_primary_10_3390_ijerph20186742 crossref_primary_10_3892_ol_2025_15021 crossref_primary_10_17650_1726_9784_2025_24_1_27_33 crossref_primary_10_1186_s12885_025_14600_3 crossref_primary_10_1002_cbf_3601 crossref_primary_10_1016_j_biopha_2022_114084 crossref_primary_10_5144_0256_4947_2020_25 crossref_primary_10_3390_cimb46090550 crossref_primary_10_1016_j_nurpra_2021_09_024 crossref_primary_10_1186_s12889_024_19287_y crossref_primary_10_3389_fonc_2025_1611007 crossref_primary_10_1007_s11033_021_06509_4 crossref_primary_10_1002_cam4_71094 crossref_primary_10_1155_2020_3598417 crossref_primary_10_1002_tox_22657 crossref_primary_10_1016_j_ijrobp_2021_12_006 crossref_primary_10_1039_D0RA05207H crossref_primary_10_3389_fonc_2025_1654730 crossref_primary_10_1016_j_ygyno_2022_01_006 crossref_primary_10_1186_s12985_021_01732_8 crossref_primary_10_3390_ijerph19159207 crossref_primary_10_1007_s12672_025_02939_9 crossref_primary_10_1016_j_bioorg_2021_105488 crossref_primary_10_3892_mco_2024_2774 crossref_primary_10_1016_j_jcpo_2022_100339 crossref_primary_10_1177_02841851211058934 crossref_primary_10_1186_s12957_021_02317_z crossref_primary_10_1002_jmv_29413 crossref_primary_10_1186_s12935_021_01867_2 crossref_primary_10_1002_mc_23559 crossref_primary_10_3233_JIFS_221604 crossref_primary_10_1007_s12020_022_02992_2 crossref_primary_10_1016_j_lfs_2025_123800 crossref_primary_10_1186_s13000_021_01145_9 crossref_primary_10_1016_j_brachy_2024_03_003 crossref_primary_10_1111_ajo_13553 crossref_primary_10_1186_s12885_020_07039_1 crossref_primary_10_1186_s12889_024_20389_w crossref_primary_10_3389_fnut_2024_1464046 crossref_primary_10_1007_s10147_019_01507_w crossref_primary_10_1186_s13000_018_0709_9 crossref_primary_10_3389_fcell_2024_1308730 crossref_primary_10_1038_s41379_022_01052_4 crossref_primary_10_1097_MD_0000000000016421 crossref_primary_10_1186_s12943_018_0847_4 crossref_primary_10_1007_s43032_023_01432_4 crossref_primary_10_1016_j_cca_2024_120103 crossref_primary_10_1002_jmv_28579 crossref_primary_10_3233_THC_212890 crossref_primary_10_3389_fimmu_2024_1351287 crossref_primary_10_1093_carcin_bgad008 crossref_primary_10_1007_s00432_022_04558_1 crossref_primary_10_7759_cureus_13789 crossref_primary_10_1155_2022_2028082 crossref_primary_10_1177_20503121241252265 crossref_primary_10_3389_fgene_2022_921306 crossref_primary_10_1016_j_jddst_2019_101300 crossref_primary_10_1016_j_bbrep_2025_101987 crossref_primary_10_1097_MD_0000000000032651 crossref_primary_10_1038_s41392_021_00507_5 crossref_primary_10_1158_1541_7786_MCR_23_0478 crossref_primary_10_1002_kjm2_70093 crossref_primary_10_31083_j_ceog4912273 crossref_primary_10_1038_s41419_021_04388_y crossref_primary_10_1186_s13063_018_2858_2 crossref_primary_10_1016_j_tvr_2025_200323 crossref_primary_10_1186_s12935_021_01749_7 crossref_primary_10_1186_s12885_022_09826_4 crossref_primary_10_3389_fonc_2020_587132 crossref_primary_10_1002_ijgo_13185 crossref_primary_10_3390_ijerph19095591 crossref_primary_10_1016_j_etap_2020_103514 crossref_primary_10_1002_jcp_29667 crossref_primary_10_3892_ol_2019_11180 crossref_primary_10_1080_01443615_2024_2311658 crossref_primary_10_1016_j_semradonc_2020_05_004 crossref_primary_10_1016_j_pdpdt_2020_102172 crossref_primary_10_1039_D2RA03055A crossref_primary_10_3892_br_2025_2010 crossref_primary_10_3390_diseases13030070 crossref_primary_10_3390_bioengineering9120740 crossref_primary_10_1016_j_neucom_2020_06_006 crossref_primary_10_1016_j_canlet_2019_06_015 crossref_primary_10_1093_hmg_ddac130 crossref_primary_10_1007_s11224_020_01497_w crossref_primary_10_1002_slct_202200082 crossref_primary_10_3390_ijms22168693 crossref_primary_10_1002_jmri_28676 crossref_primary_10_1002_jmv_70564 crossref_primary_10_1002_cbin_11744 crossref_primary_10_1111_jocn_17067 crossref_primary_10_1016_j_ejphar_2018_11_043 crossref_primary_10_1200_GO_21_00151 crossref_primary_10_1016_j_ejogrb_2020_07_054 crossref_primary_10_1016_j_mri_2022_06_007 crossref_primary_10_1097_MD_0000000000022950 crossref_primary_10_1016_j_yfpn_2021_01_009 crossref_primary_10_31083_j_ceog5108186 crossref_primary_10_1155_2022_5936773 crossref_primary_10_4236_health_2023_156036 crossref_primary_10_1016_j_bjp_2019_06_004 crossref_primary_10_1053_j_sult_2025_09_007 crossref_primary_10_1016_j_fct_2020_111843 crossref_primary_10_1016_j_prp_2024_155612 crossref_primary_10_1016_j_prenap_2025_100272 crossref_primary_10_1093_lambio_ovaf088 crossref_primary_10_1155_2022_5435333 crossref_primary_10_1002_ange_202423207 crossref_primary_10_1007_s43032_021_00806_w crossref_primary_10_1007_s00216_022_04296_w crossref_primary_10_7759_cureus_90543 crossref_primary_10_3389_fcell_2021_670890 crossref_primary_10_1186_s11658_024_00532_6 crossref_primary_10_1002_acm2_13833 crossref_primary_10_1016_j_biopha_2023_114518 crossref_primary_10_1016_j_tjog_2020_03_012 crossref_primary_10_1002_nop2_1460 crossref_primary_10_1186_s12905_024_02905_7 crossref_primary_10_1016_j_abb_2022_109389 crossref_primary_10_2147_MDER_S366303 crossref_primary_10_1016_j_humimm_2020_07_002 crossref_primary_10_1089_hum_2017_197 crossref_primary_10_1016_j_vaccine_2022_12_027 crossref_primary_10_1155_2022_7728739 crossref_primary_10_1186_s12905_021_01588_8 crossref_primary_10_3389_fonc_2022_904790 crossref_primary_10_1111_jog_15815 crossref_primary_10_1002_jcp_29783 crossref_primary_10_1016_j_biopha_2020_110209 crossref_primary_10_1016_j_prp_2019_01_004 crossref_primary_10_1097_JCMA_0000000000000613 crossref_primary_10_1155_2022_8736575 crossref_primary_10_1002_jmv_25899 crossref_primary_10_1007_s13224_025_02202_9 crossref_primary_10_1016_j_gore_2018_07_001 crossref_primary_10_2217_imt_2019_0196 crossref_primary_10_1177_1533033820914983 crossref_primary_10_1039_D0RA09155C crossref_primary_10_3389_fonc_2018_00010 crossref_primary_10_1186_s12905_024_02917_3 crossref_primary_10_1007_s43032_022_01032_8 crossref_primary_10_1016_j_biopha_2020_110331 crossref_primary_10_3389_fphar_2023_1129874 crossref_primary_10_1186_s12885_020_06854_w crossref_primary_10_1038_s41419_022_05359_7 crossref_primary_10_3390_molecules27051582 crossref_primary_10_1186_s12943_020_01204_7 crossref_primary_10_1186_s41065_025_00520_6 crossref_primary_10_1186_s41065_025_00478_5 crossref_primary_10_1097_MD_0000000000033820 crossref_primary_10_3389_fgene_2020_00819 crossref_primary_10_3390_s25092826 crossref_primary_10_1007_s10552_021_01475_5 crossref_primary_10_2174_0115733947308352240729162826 crossref_primary_10_1016_j_tranon_2021_101015 crossref_primary_10_1016_j_lfs_2023_121998 crossref_primary_10_1038_s41389_019_0179_2 crossref_primary_10_1097_RCT_0000000000001358 crossref_primary_10_13005_bpj_2364 crossref_primary_10_7759_cureus_86032 crossref_primary_10_1016_j_bbcan_2023_188894 crossref_primary_10_3390_ijms25042237 crossref_primary_10_3390_cancers16071250 crossref_primary_10_1016_j_suronc_2018_05_013 crossref_primary_10_1016_j_micpath_2024_106764 crossref_primary_10_1080_09513590_2020_1770722 crossref_primary_10_3390_vaccines12111262 crossref_primary_10_1016_j_phymed_2019_152973 crossref_primary_10_7717_peerj_17842 crossref_primary_10_1016_j_heliyon_2020_e03862 crossref_primary_10_3390_cancers13092092 crossref_primary_10_3390_cells11193074 crossref_primary_10_1002_anie_202104304 crossref_primary_10_1002_hed_27603 crossref_primary_10_3389_fcell_2021_757184 crossref_primary_10_1038_s41598_024_54314_3 crossref_primary_10_3892_ol_2024_14461 crossref_primary_10_1016_j_gore_2021_100916 crossref_primary_10_1371_journal_pone_0226258 crossref_primary_10_3390_pharmaceutics14020365 crossref_primary_10_1016_j_cca_2023_117618 crossref_primary_10_1186_s13104_025_07401_1 crossref_primary_10_7759_cureus_36946 crossref_primary_10_1016_j_heliyon_2024_e40860 crossref_primary_10_1080_07357907_2024_2359987 crossref_primary_10_1186_s12935_021_01802_5 crossref_primary_10_1007_s13187_023_02373_x crossref_primary_10_22207_JPAM_16_3_05 crossref_primary_10_1016_j_procbio_2024_01_028 crossref_primary_10_1016_j_cmi_2025_07_004 crossref_primary_10_1002_ijgo_14442 crossref_primary_10_1038_s41467_025_62589_x crossref_primary_10_2174_0109298673315699240805111122 crossref_primary_10_3390_vaccines10122064 crossref_primary_10_3389_fcell_2021_655018 crossref_primary_10_3389_fonc_2021_712849 crossref_primary_10_1016_j_mri_2021_12_008 crossref_primary_10_1186_s12935_024_03537_5 crossref_primary_10_1021_acsami_5c10644 crossref_primary_10_1186_s12905_024_02907_5 crossref_primary_10_1038_s41419_018_1228_z crossref_primary_10_52711_0974_360X_2023_00590 crossref_primary_10_3389_fphar_2024_1476152 crossref_primary_10_1007_s12094_021_02751_1 crossref_primary_10_1136_ijgc_2018_000095 crossref_primary_10_1097_CEJ_0000000000000849 crossref_primary_10_1038_s41598_024_81726_y crossref_primary_10_1159_000507937 crossref_primary_10_3390_ph17101320 crossref_primary_10_1155_2022_1056825 crossref_primary_10_1016_j_tjog_2021_03_008 crossref_primary_10_1016_j_prp_2022_154090 crossref_primary_10_1007_s12094_022_02904_w crossref_primary_10_1111_srt_70042 crossref_primary_10_3390_antiox12101806 |
| Cites_doi | 10.1016/S1470-2045(09)70360-2 10.1080/14760584.2016.1176533 10.1016/j.ijrobp.2011.05.002 10.1016/j.ijrobp.2014.07.017 10.3802/jgo.2016.27.e51 10.1016/j.ygyno.2014.12.022 10.1007/s11912-014-0416-y 10.1016/j.ijrobp.2006.12.013 10.1093/annonc/mdq162 10.1016/j.ijrobp.2015.02.054 10.1056/NEJM199904153401501 10.1016/j.ejca.2011.01.008 10.1016/j.ijrobp.2013.05.033 10.1200/JCO.1999.17.5.1339 10.1016/S0140-6736(09)61248-4 10.1016/j.ijrobp.2011.05.052 10.1038/nature12881 10.1371/journal.pmed.1001499 10.1016/j.ijrobp.2008.03.032 10.1002/cncr.28288 10.1002/1097-0142(19830415)51:8<1393::AID-CNCR2820510812>3.0.CO;2-M 10.1016/j.brachy.2011.07.002 10.1056/NEJM199904153401502 10.1006/gyno.1994.1137 10.6004/jnccn.2015.0055 10.1097/IGC.0b013e31823ae3c9 10.1016/j.ajog.2007.08.003 10.1016/B978-0-443-07142-3.50008-7 10.1016/j.ijrobp.2013.12.008 10.1056/NEJMoa073204 10.1200/JCO.2006.09.4532 10.1016/j.ijrobp.2013.11.011 10.1056/NEJM199904153401503 10.1002/ijc.25516 10.1111/IGC.0b013e3181b62e73 10.1200/JCO.2008.16.4368 10.1186/1743-422X-9-52 10.1056/NEJMoa061741 10.1056/NEJMoa1405044 10.1002/1097-0142(19830301)51:5<959::AID-CNCR2820510533>3.0.CO;2-K 10.1016/0360-3016(91)90143-R 10.1016/S1470-2045(09)70156-1 10.1016/j.ijrobp.2013.11.228 10.1016/S0140-6736(97)02250-2 10.1016/j.radonc.2011.07.012 10.1016/S1470-2045(09)70335-3 10.1186/s12889-015-1779-1 10.1093/bmb/ldg014 10.1016/S0140-6736(09)62163-2 10.1002/1097-0142(19860101)57:1<148::AID-CNCR2820570130>3.0.CO;2-7 10.1006/gyno.1999.5387 10.1016/S0140-6736(07)61450-0 10.1200/JGO.2016.003954 10.1001/jama.2013.1625 10.1542/peds.2014-3745 10.1371/journal.pone.0078411 10.1016/j.radonc.2016.03.011 10.1016/j.ijrobp.2005.04.035 10.1016/0360-3016(94)90148-1 10.1016/S1470-2045(15)00222-3 10.1200/JCO.2004.07.197 |
| ContentType | Journal Article |
| Copyright | 2017 American Cancer Society 2017 American Cancer Society. |
| Copyright_xml | – notice: 2017 American Cancer Society – notice: 2017 American Cancer Society. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TO 7U7 C1K H94 K9. NAPCQ 7X8 |
| DOI | 10.1002/cncr.30667 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Oncogenes and Growth Factors Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Oncogenes and Growth Factors Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitleList | MEDLINE AIDS and Cancer Research Abstracts CrossRef MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1097-0142 |
| EndPage | 2412 |
| ExternalDocumentID | 28464289 10_1002_cncr_30667 CNCR30667 |
| Genre | reviewArticle Journal Article Review |
| GroupedDBID | --- -~X .3N .GA 05W 0R~ 10A 1CY 1L6 1OC 24P 29B 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5VS 66C 6J9 6P2 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 85S 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AAQOH AARRQ AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABHFT ABIJN ABIVO ABJNI ABLJU ABOCM ABPPZ ABPVW ABQWH ABXGK ACAHQ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACNCT ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEIGN AEIMD AENEX AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AIACR AIAGR AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EJD EMOBN EX3 F00 F01 F04 F5P FD6 FUBAC G-S G.N GNP GODZA GX1 H.X HBH HGLYW HHY HHZ HZ~ IH2 IX1 J0M JPC KBYEO KQQ KZ1 L7B LATKE LAW LC2 LC3 LH4 LITHE LMP LOXES LP6 LP7 LSO LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 QRW R.K ROL RWI RX1 RYL SJN SUPJJ TEORI UDS UHB V2E V8K V9Y W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WIN WJL WOHZO WQJ WRC WVDHM WXI WXSBR XG1 XPP XV2 Z0Y ZGI ZZTAW ~IA ~WT .GJ .Y3 31~ 3O- AAMMB AAYXX AEFGJ AEYWJ AFFNX AGHNM AGNAY AGXDD AGYGG AI. AIDQK AIDYY C1A CITATION HF~ H~9 J5H N4W NEJ O8X OHT RSU VH1 WHG Y6R YQJ ZXP CGR CUY CVF ECM EIF NPM 7TO 7U7 C1K H94 K9. NAPCQ 7X8 |
| ID | FETCH-LOGICAL-c4237-f181fe592128afd04aca9199f334d69b1ead7a810d82fa00e32750cfd8f4ffc3 |
| IEDL.DBID | WIN |
| ISICitedReferencesCount | 934 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000403469500007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0008-543X 1097-0142 |
| IngestDate | Thu Oct 02 06:08:29 EDT 2025 Tue Oct 07 07:01:48 EDT 2025 Wed Feb 19 02:16:32 EST 2025 Sat Nov 29 07:17:55 EST 2025 Tue Nov 18 20:55:50 EST 2025 Wed Jan 22 16:58:27 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 13 |
| Keywords | human papillomavirus (HPV) developing world Cervix Cancer Research Network (CCRN) Gynecological Cancer InterGroup (GCIG) brachytherapy cervical cancer chemotherapy activism vaccination |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2017 American Cancer Society. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4237-f181fe592128afd04aca9199f334d69b1ead7a810d82fa00e32750cfd8f4ffc3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0002-1623-9863 |
| PMID | 28464289 |
| PQID | 1920462280 |
| PQPubID | 2045183 |
| PageCount | 10 |
| ParticipantIDs | proquest_miscellaneous_1894918443 proquest_journals_1920462280 pubmed_primary_28464289 crossref_citationtrail_10_1002_cncr_30667 crossref_primary_10_1002_cncr_30667 wiley_primary_10_1002_cncr_30667_CNCR30667 |
| PublicationCentury | 2000 |
| PublicationDate | July 1, 2017 |
| PublicationDateYYYYMMDD | 2017-07-01 |
| PublicationDate_xml | – month: 07 year: 2017 text: July 1, 2017 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Atlanta |
| PublicationTitle | Cancer |
| PublicationTitleAlternate | Cancer |
| PublicationYear | 2017 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | 2004; 22 2010; 11 1997; 350 2005; 63 1983; 51 1994; 28 2013; 8 2012; 11 2008; 71 2015; 372 2010; 21 2009; 10 2007; 370 2013; 119 2013; 10 2015; 136 1999; 17 2014; 16 2008; 26 2009; 19 2012; 22 2007; 68 2007; 25 2015; 13 2012; 83 2015; 15 2015; 16 2014; 90 2015; 92 2013; 87 2013; 309 2010; 127 2011; 81 1986; 57 1999; 340 2009; 374 2004 2016; 15 2016; 120 2014; 89 2014; 88 2007; 356 2007; 357 2016; 2 2014; 506 2015; 64 1991; 20 2007; 197 2003; 24 2010; 375 2016; 62 2017 2016 2015 1999; 73 2011; 47 2013 2016; 27 2011; 100 2012; 9 1994; 53 2003; 67 Gadducci A (e_1_2_4_7_1) 2003; 24 e_1_2_4_40_1 e_1_2_4_63_1 e_1_2_4_61_1 e_1_2_4_21_1 e_1_2_4_44_1 e_1_2_4_67_1 e_1_2_4_23_1 e_1_2_4_65_1 e_1_2_4_25_1 e_1_2_4_48_1 e_1_2_4_27_1 e_1_2_4_46_1 e_1_2_4_69_1 e_1_2_4_29_1 e_1_2_4_3_1 e_1_2_4_5_1 American Academy of Pediatrics (e_1_2_4_38_1) 2015 e_1_2_4_9_1 e_1_2_4_52_1 e_1_2_4_73_1 e_1_2_4_50_1 e_1_2_4_71_1 e_1_2_4_10_1 e_1_2_4_31_1 e_1_2_4_56_1 e_1_2_4_12_1 e_1_2_4_33_1 e_1_2_4_54_1 e_1_2_4_75_1 e_1_2_4_14_1 e_1_2_4_35_1 e_1_2_4_16_1 Ferlay J (e_1_2_4_68_1) 2013 e_1_2_4_37_1 e_1_2_4_58_1 e_1_2_4_18_1 e_1_2_4_39_1 e_1_2_4_41_1 e_1_2_4_62_1 e_1_2_4_60_1 e_1_2_4_20_1 e_1_2_4_66_1 e_1_2_4_22_1 e_1_2_4_43_1 Yang DY (e_1_2_4_45_1) 2016; 62 e_1_2_4_64_1 e_1_2_4_24_1 e_1_2_4_49_1 e_1_2_4_26_1 e_1_2_4_47_1 e_1_2_4_28_1 Petrosky E (e_1_2_4_42_1) 2015; 64 e_1_2_4_2_1 e_1_2_4_4_1 e_1_2_4_70_1 e_1_2_4_6_1 e_1_2_4_8_1 e_1_2_4_51_1 e_1_2_4_74_1 e_1_2_4_30_1 e_1_2_4_72_1 e_1_2_4_32_1 e_1_2_4_55_1 e_1_2_4_11_1 e_1_2_4_34_1 e_1_2_4_53_1 e_1_2_4_13_1 e_1_2_4_36_1 e_1_2_4_59_1 e_1_2_4_15_1 e_1_2_4_57_1 e_1_2_4_17_1 e_1_2_4_19_1 |
| References_xml | – volume: 68 start-page: 485 year: 2007 end-page: 490 article-title: Practice patterns of radiotherapy in cervical cancer among member groups of the Gynecologic Cancer Intergroup (GCIG) publication-title: Int J Radiat Oncol Biol Phys. – volume: 11 start-page: 165 year: 2010 end-page: 173 article-title: Cancer survival in Africa, Asia, and Central America: a population‐based study publication-title: Lancet Oncol. – volume: 51 start-page: 1393 year: 1983 end-page: 1402 article-title: Radiation therapy alone in the treatment of carcinoma of uterine cervix. I. Analysis of tumor recurrence publication-title: Cancer. – volume: 370 start-page: 1764 year: 2007 end-page: 1772 article-title: Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5‐year follow‐up of a randomised controlled implementation trial publication-title: Lancet. – volume: 64 start-page: 300 year: 2015 end-page: 304 article-title: Use of 9‐valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices publication-title: MMWR Morb Mortal Wkly Rep. – volume: 197 start-page: 503 year: 2007 article-title: Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow‐up of a Gynecologic Oncology Group trial publication-title: Am J Obstet Gynecol. – volume: 89 start-page: 249 year: 2014 end-page: 256 article-title: Patterns of radiation therapy practice for patients treated for intact cervical cancer in 2005 to 2007: a quality research in radiation oncology study publication-title: Int J Radiat Oncol Biol Phys. – volume: 16 start-page: 1153 year: 2015 end-page: 1186 article-title: Expanding global access to radiotherapy publication-title: Lancet Oncol. – volume: 136 start-page: e28 year: 2015 end-page: e39 article-title: Immunogenicity and safety of a 9‐valent HPV vaccine publication-title: Pediatrics. – volume: 340 start-page: 1144 year: 1999 end-page: 1153 article-title: Concurrent cisplatin‐based radiotherapy and chemotherapy for locally advanced cervical cancer publication-title: N Engl J Med. – volume: 350 start-page: 535 year: 1997 end-page: 540 article-title: Randomised study of radical surgery versus radiotherapy for stage Ib‐IIa cervical cancer publication-title: Lancet. – volume: 71 start-page: 1272 year: 2008 end-page: 1278 article-title: Image‐guided radiotherapy for cervix cancer: high‐tech external beam therapy versus high‐tech brachytherapy publication-title: Int J Radiat Oncol Biol Phys. – volume: 20 start-page: 95 year: 1991 end-page: 100 article-title: Tumor and treatment factors improving outcome in stage III‐B cervix cancer publication-title: Int J Radiat Oncol Biol Phys. – volume: 374 start-page: 301 year: 2009 end-page: 314 article-title: Efficacy of human papillomavirus (HPV)‐16/18 AS04‐adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double‐blind, randomised study in young women publication-title: Lancet. – volume: 100 start-page: 116 year: 2011 end-page: 123 article-title: Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer publication-title: Radiother Oncol. – volume: 88 start-page: 537 year: 2014 end-page: 539 article-title: Curative radiation therapy for locally advanced cervical cancer: brachytherapy is NOT optional publication-title: Int J Radiat Oncol Biol Phys. – volume: 2 start-page: 311 year: 2016 end-page: 340 article-title: Management and care of women with invasive cervical cancer: American Society of Clinical Oncology Resource‐Stratified Clinical Practice Guideline publication-title: J Global Oncol. – start-page: 576 year: 2015 end-page: 583 – volume: 28 start-page: 113 year: 1994 end-page: 118 article-title: The relationship between brachytherapy dose and outcome in patients with bulky endocervical tumors treated with radiation alone publication-title: Int J Radiat Oncol Biol Phys. – volume: 26 start-page: 5802 year: 2008 end-page: 5812 article-title: Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta‐analysis of individual patient data from 18 randomized trials publication-title: J Clin Oncol. – volume: 127 start-page: 2893 year: 2010 end-page: 2917 article-title: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 publication-title: Int J Cancer. – volume: 120 start-page: 428 year: 2016 end-page: 433 article-title: Image guided brachytherapy in locally advanced cervical cancer: improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study publication-title: Radiother Oncol. – volume: 16 start-page: 416 year: 2014 article-title: Adenocarcinoma of the uterine cervix: why is it different? publication-title: Curr Oncol Rep. – volume: 81 start-page: e577 year: 2011 end-page: e581 article-title: Randomized clinical trial of weekly vs. triweekly cisplatin‐based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer publication-title: Int J Radiat Oncol Biol Phys. – volume: 89 start-page: 462 year: 2014 end-page: 467 article-title: Implementation of a high‐dose‐rate brachytherapy program for carcinoma of the cervix in Senegal: a pragmatic model for the developing world publication-title: Int J Radiat Oncol Biol Phys. – volume: 24 start-page: 513 year: 2003 end-page: 516 article-title: The clinical outcome of patients with stage Ia1 and Ia2 squamous cell carcinoma of the uterine cervix: a Cooperation Task Force (CTF) study publication-title: Eur J Gynaecol Oncol. – volume: 83 start-page: 178 year: 2012 end-page: 184 article-title: Trends in the utilization of adjuvant vaginal cuff brachytherapy and/or external beam radiation treatment in stage I and II endometrial cancer: a Surveillance, Epidemiology, and End‐Results study publication-title: Int J Radiat Oncol Biol Phys. – volume: 19 start-page: 1402 year: 2009 end-page: 1406 article-title: Increasing brachytherapy dose predicts survival for interstitial and tandem‐based radiation for stage IIIB cervical cancer publication-title: Int J Gynecol Cancer. – volume: 506 start-page: 371 year: 2014 end-page: 375 article-title: Landscape of genomic alterations in cervical carcinomas publication-title: Nature. – volume: 8 start-page: e78411 year: 2013 article-title: Analysis of factors contributing to the low survival of cervical cancer patients undergoing radiotherapy in Kenya publication-title: PLoS One. – volume: 67 start-page: 13 year: 2003 end-page: 25 article-title: Safe motherhood: a brief history of the global movement 1947‐2002 publication-title: Br Med Bull. – volume: 27 start-page: e51 year: 2016 article-title: Immonotherapy for human papillomavirus‐associated disease and cervical cancer: review of clinical and translational research publication-title: J Gynecol Oncol. – volume: 309 start-page: 1793 year: 2013 end-page: 1802 article-title: Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial publication-title: JAMA. – volume: 372 start-page: 711 year: 2015 end-page: 723 article-title: A 9‐valent HPV vaccine against infection and intraepithelial neoplasia in women publication-title: N Engl J Med. – volume: 73 start-page: 177 year: 1999 end-page: 183 article-title: A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study publication-title: Gynecol Oncol. – volume: 13 start-page: 395 year: 2015 end-page: 404 article-title: Cervical cancer, version 2.2015 publication-title: J Natl Compr Canc Netw. – volume: 87 start-page: 111 year: 2013 end-page: 119 article-title: Trends in the utilization of brachytherapy in cervical cancer in the United States publication-title: Int J Radiat Oncol Biol Phys. – volume: 21 start-page: v37 issue: 5 suppl year: 2010 end-page: v40 article-title: Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow‐up publication-title: Ann Oncol. – volume: 9 start-page: 52 year: 2012 article-title: Disassembly and reassembly of human papillomavirus virus‐like particles produces more virion‐like antibody reactivity publication-title: Virol J. – volume: 11 start-page: 249 year: 2010 end-page: 257 article-title: Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial publication-title: Lancet Oncol. – volume: 47 start-page: 864 year: 2011 end-page: 871 article-title: A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial publication-title: Eur J Cancer. – volume: 136 start-page: 178 year: 2015 end-page: 182 article-title: Use of primary high‐risk human papillomavirus testing for cervical cancer screening: interim clinical guidance publication-title: Gynecol Oncol. – volume: 22 start-page: 872 year: 2004 end-page: 880 article-title: Pelvic irradiation with concurrent chemotherapy versus pelvic and para‐aortic irradiation for high‐risk cervical cancer: an update of Radiation Therapy Oncology Group trial (RTOG) 90‐01 publication-title: J Clin Oncol. – volume: 92 start-page: 506 year: 2015 end-page: 508 article-title: The Cervix Cancer Research Network: a global outreach effort on behalf of the Gynecologic Cancer InterGroup publication-title: Int J Radiat Oncol Biol Phys. – volume: 53 start-page: 294 year: 1994 end-page: 300 article-title: Technically accurate intracavitary insertions improve pelvic control and survival among patients with locally advanced carcinoma of the uterine cervix publication-title: Gynecol Oncol. – volume: 11 start-page: 47 year: 2012 end-page: 52 article-title: American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high‐dose‐rate brachytherapy publication-title: Brachytherapy. – year: 2016 – volume: 90 start-page: 1083 year: 2014 end-page: 1090 article-title: National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements publication-title: Int J Radiat Oncol Biol Phys. – start-page: 65 year: 2004 end-page: 78 – volume: 375 start-page: 816 year: 2010 end-page: 823 article-title: Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high‐intermediate risk (PORTEC‐2): an open‐label, non‐inferiority, randomised trial publication-title: Lancet. – volume: 357 start-page: 1589 year: 2007 end-page: 1597 article-title: Human papillomavirus and Papanicolaou tests to screen for cervical cancer publication-title: N Engl J Med. – volume: 22 start-page: 123 year: 2012 end-page: 131 article-title: The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease‐free survival in Radiation Therapy Oncology Group prospective trials 0116 and 0128 publication-title: Int J Gynecol Cancer. – volume: 340 start-page: 1154 year: 1999 end-page: 1161 article-title: Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma publication-title: N Engl J Med. – volume: 15 start-page: 453 year: 2015 article-title: Potential impact of a nonavalent HPV vaccine on the occurrence of HPV‐related diseases in France publication-title: BMC Public Health. – volume: 57 start-page: 148 year: 1986 end-page: 154 article-title: Carcinoma of the cervix, stage III. Results of radiation therapy publication-title: Cancer. – volume: 25 start-page: 2804 year: 2007 end-page: 2810 article-title: Long‐term follow‐up of a randomized trial comparing concurrent single agent cisplatin, cisplatin‐based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study publication-title: J Clin Oncol. – volume: 10 start-page: 672 year: 2009 end-page: 682 article-title: HPV testing in combination with liquid‐based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial publication-title: Lancet Oncol. – volume: 17 start-page: 1339 year: 1999 end-page: 1348 article-title: Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB‐IVA carcinoma of the cervix with negative para‐aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study publication-title: J Clin Oncol. – volume: 62 start-page: 399 year: 2016 end-page: 402 article-title: Update on the new 9‐valent vaccine for human papillomavirus prevention publication-title: Can Fam Physician. – volume: 356 start-page: 1915 year: 2007 end-page: 1927 article-title: Quadrivalent vaccine against human papillomavirus to prevent high‐grade cervical lesions publication-title: N Engl J Med. – volume: 63 start-page: 1083 year: 2005 end-page: 1092 article-title: Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996‐1999): a patterns of care study publication-title: Int J Radiat Oncol Biol Phys. – volume: 51 start-page: 959 year: 1983 end-page: 967 article-title: Patterns of care outcome studies. Results of the national practice in cancer of the cervix publication-title: Cancer. – volume: 10 start-page: e1001499 year: 2013 article-title: Reproductive and maternal health in the post‐2015 era: cervical cancer must be a priority publication-title: PLoS Med. – volume: 340 start-page: 1137 year: 1999 end-page: 1143 article-title: Pelvic radiation with concurrent chemotherapy compared with pelvic and para‐aortic radiation for high‐risk cervical cancer publication-title: N Engl J Med. – year: 2017 – volume: 119 start-page: 3776 year: 2013 end-page: 3783 article-title: Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix publication-title: Cancer. – volume: 15 start-page: 1327 year: 2016 end-page: 1336 article-title: Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies publication-title: Expert Rev Vaccines. – year: 2013 – ident: e_1_2_4_32_1 doi: 10.1016/S1470-2045(09)70360-2 – ident: e_1_2_4_46_1 doi: 10.1080/14760584.2016.1176533 – ident: e_1_2_4_51_1 doi: 10.1016/j.ijrobp.2011.05.002 – ident: e_1_2_4_66_1 doi: 10.1016/j.ijrobp.2014.07.017 – ident: e_1_2_4_26_1 doi: 10.3802/jgo.2016.27.e51 – ident: e_1_2_4_34_1 doi: 10.1016/j.ygyno.2014.12.022 – ident: e_1_2_4_25_1 doi: 10.1007/s11912-014-0416-y – volume: 62 start-page: 399 year: 2016 ident: e_1_2_4_45_1 article-title: Update on the new 9‐valent vaccine for human papillomavirus prevention publication-title: Can Fam Physician. – ident: e_1_2_4_49_1 doi: 10.1016/j.ijrobp.2006.12.013 – ident: e_1_2_4_53_1 doi: 10.1093/annonc/mdq162 – ident: e_1_2_4_47_1 doi: 10.1016/j.ijrobp.2015.02.054 – ident: e_1_2_4_9_1 doi: 10.1056/NEJM199904153401501 – ident: e_1_2_4_33_1 doi: 10.1016/j.ejca.2011.01.008 – ident: e_1_2_4_55_1 doi: 10.1016/j.ijrobp.2013.05.033 – ident: e_1_2_4_11_1 doi: 10.1200/JCO.1999.17.5.1339 – ident: e_1_2_4_4_1 – ident: e_1_2_4_37_1 doi: 10.1016/S0140-6736(09)61248-4 – ident: e_1_2_4_57_1 doi: 10.1016/j.ijrobp.2011.05.052 – ident: e_1_2_4_28_1 doi: 10.1038/nature12881 – volume-title: GLOBOCAN 2012 v1.0: Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 year: 2013 ident: e_1_2_4_68_1 – ident: e_1_2_4_75_1 doi: 10.1371/journal.pmed.1001499 – ident: e_1_2_4_56_1 doi: 10.1016/j.ijrobp.2008.03.032 – ident: e_1_2_4_27_1 doi: 10.1002/cncr.28288 – volume: 24 start-page: 513 year: 2003 ident: e_1_2_4_7_1 article-title: The clinical outcome of patients with stage Ia1 and Ia2 squamous cell carcinoma of the uterine cervix: a Cooperation Task Force (CTF) study publication-title: Eur J Gynaecol Oncol. – ident: e_1_2_4_18_1 doi: 10.1002/1097-0142(19830415)51:8<1393::AID-CNCR2820510812>3.0.CO;2-M – ident: e_1_2_4_3_1 – ident: e_1_2_4_52_1 – ident: e_1_2_4_54_1 doi: 10.1016/j.brachy.2011.07.002 – ident: e_1_2_4_10_1 doi: 10.1056/NEJM199904153401502 – ident: e_1_2_4_62_1 doi: 10.1006/gyno.1994.1137 – ident: e_1_2_4_48_1 doi: 10.6004/jnccn.2015.0055 – ident: e_1_2_4_63_1 doi: 10.1097/IGC.0b013e31823ae3c9 – ident: e_1_2_4_15_1 doi: 10.1016/j.ajog.2007.08.003 – ident: e_1_2_4_23_1 doi: 10.1016/B978-0-443-07142-3.50008-7 – ident: e_1_2_4_72_1 doi: 10.1016/j.ijrobp.2013.12.008 – ident: e_1_2_4_31_1 doi: 10.1056/NEJMoa073204 – ident: e_1_2_4_13_1 doi: 10.1200/JCO.2006.09.4532 – ident: e_1_2_4_21_1 doi: 10.1016/j.ijrobp.2013.11.011 – ident: e_1_2_4_14_1 doi: 10.1056/NEJM199904153401503 – ident: e_1_2_4_71_1 doi: 10.1002/ijc.25516 – ident: e_1_2_4_20_1 doi: 10.1111/IGC.0b013e3181b62e73 – ident: e_1_2_4_50_1 doi: 10.1200/JCO.2008.16.4368 – ident: e_1_2_4_35_1 doi: 10.1186/1743-422X-9-52 – ident: e_1_2_4_36_1 doi: 10.1056/NEJMoa061741 – ident: e_1_2_4_73_1 – ident: e_1_2_4_40_1 doi: 10.1056/NEJMoa1405044 – volume: 64 start-page: 300 year: 2015 ident: e_1_2_4_42_1 article-title: Use of 9‐valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices publication-title: MMWR Morb Mortal Wkly Rep. – ident: e_1_2_4_61_1 doi: 10.1002/1097-0142(19830301)51:5<959::AID-CNCR2820510533>3.0.CO;2-K – ident: e_1_2_4_60_1 doi: 10.1016/0360-3016(91)90143-R – ident: e_1_2_4_30_1 doi: 10.1016/S1470-2045(09)70156-1 – ident: e_1_2_4_65_1 doi: 10.1016/j.ijrobp.2013.11.228 – ident: e_1_2_4_6_1 doi: 10.1016/S0140-6736(97)02250-2 – ident: e_1_2_4_16_1 doi: 10.1016/j.radonc.2011.07.012 – ident: e_1_2_4_22_1 doi: 10.1016/S1470-2045(09)70335-3 – ident: e_1_2_4_44_1 doi: 10.1186/s12889-015-1779-1 – ident: e_1_2_4_74_1 doi: 10.1093/bmb/ldg014 – ident: e_1_2_4_58_1 doi: 10.1016/S0140-6736(09)62163-2 – ident: e_1_2_4_59_1 doi: 10.1002/1097-0142(19860101)57:1<148::AID-CNCR2820570130>3.0.CO;2-7 – ident: e_1_2_4_5_1 – ident: e_1_2_4_8_1 doi: 10.1006/gyno.1999.5387 – ident: e_1_2_4_29_1 doi: 10.1016/S0140-6736(07)61450-0 – ident: e_1_2_4_69_1 doi: 10.1200/JGO.2016.003954 – ident: e_1_2_4_24_1 – ident: e_1_2_4_39_1 doi: 10.1001/jama.2013.1625 – ident: e_1_2_4_41_1 doi: 10.1542/peds.2014-3745 – ident: e_1_2_4_67_1 doi: 10.1371/journal.pone.0078411 – ident: e_1_2_4_17_1 doi: 10.1016/j.radonc.2016.03.011 – start-page: 576 volume-title: Red Book: 2015 Report of the Committee on Infectious Diseases year: 2015 ident: e_1_2_4_38_1 – ident: e_1_2_4_2_1 – ident: e_1_2_4_64_1 doi: 10.1016/j.ijrobp.2005.04.035 – ident: e_1_2_4_19_1 doi: 10.1016/0360-3016(94)90148-1 – ident: e_1_2_4_70_1 doi: 10.1016/S1470-2045(15)00222-3 – ident: e_1_2_4_43_1 – ident: e_1_2_4_12_1 doi: 10.1200/JCO.2004.07.197 |
| SSID | ssj0007253 |
| Score | 2.6945682 |
| SecondaryResourceType | review_article |
| Snippet | Cervical cancer is the fourth most common malignancy diagnosed in women worldwide. Nearly all cases of cervical cancer result from infection with the human... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 2404 |
| SubjectTerms | activism Adenocarcinoma, Clear Cell - pathology Adenocarcinoma, Clear Cell - therapy Antineoplastic Agents - therapeutic use Biology Brachytherapy Cancer Cancer therapies Carcinoma, Adenosquamous - pathology Carcinoma, Adenosquamous - therapy Carcinoma, Neuroendocrine - pathology Carcinoma, Neuroendocrine - therapy Carcinoma, Small Cell - pathology Carcinoma, Small Cell - therapy Carcinoma, Squamous Cell - pathology Carcinoma, Squamous Cell - prevention & control Carcinoma, Squamous Cell - therapy Carcinoma, Squamous Cell - virology Cervical cancer Cervix Cervix Cancer Research Network (CCRN) Chemoradiotherapy Chemoradiotherapy, Adjuvant Chemotherapy Cisplatin Cisplatin - therapeutic use Developing countries developing world Early Detection of Cancer Early Medical Intervention Female Fertility Preservation Global Health Gynecological Cancer InterGroup (GCIG) Human papillomavirus human papillomavirus (HPV) Humans Hysterectomy Infections LDCs Malignancy Neoplasms, Cystic, Mucinous, and Serous - pathology Neoplasms, Cystic, Mucinous, and Serous - therapy Oncology Papillomavirus Infections - prevention & control Papillomavirus Vaccines - therapeutic use Prevention Radiation therapy Radiotherapy, Adjuvant Surgery Uterine Cervical Neoplasms - pathology Uterine Cervical Neoplasms - prevention & control Uterine Cervical Neoplasms - therapy Uterine Cervical Neoplasms - virology Vaccination |
| Title | Cervical cancer: A global health crisis |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcncr.30667 https://www.ncbi.nlm.nih.gov/pubmed/28464289 https://www.proquest.com/docview/1920462280 https://www.proquest.com/docview/1894918443 |
| Volume | 123 |
| WOSCitedRecordID | wos000403469500007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Journals customDbUrl: eissn: 1097-0142 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007253 issn: 0008-543X databaseCode: DRFUL dateStart: 19960101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 1097-0142 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0007253 issn: 0008-543X databaseCode: WIN dateStart: 19960101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS8MwED_mFPHF74_pHBUFUai2Sbom4otMh8IcMqburaRJA4J0sm7-_SZp1zEUQXwr9Mo1udxXcvkdwImMAxUTgVwkm9IljGOXxiJwMRY-lTrEVrZN50sn7HbpYMCeKnA9vQuT40OUG25GM6y9NgrO4-xyBhoqUjG6wKZGUxtgn_imfcHrQ7c0wyEqICg96gYED0psUnQ5-3TeG30LMecjVuty2mv_-9l1WC1CTecmXxsbUEnSTVh-LA7Tt-C0Ze2EJhFG9KMr58bJ8UGc_Hakoy1K9pZtQ79912_du0XfBFeYIhdXaa-tkoBpr0S5kh7hgjNfTzvGRDZZ7OvVE3Lqe5IixT0vwQbkXShJFVFK4B2opsM02QNHerHPBY0VCzyiY0cuTBdcKXQOpZAIvRqcTacvEgWmuGlt8R7laMgoMgOP7MBrcFzSfuRIGj9S1adSiAptyiIdhZo7tIhqhkfla60H5nCDp8lwomkoI0ynqwTXYDeXXslGu2CTZrEanFsh_cI_anVbPfu0_xfiA1hBxt_bOt46VMejSXIIS-Jz_JaNGrAQDmgDFm977edOwy7TL0UE5eg |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3rS8MwED90ivrF92M-KwqiUNcm6Zb4bQzHhlsRGbpvJU0aGEgne_j3m6Rdx1AE8VuhV9Lkcne_JJffAVzLOFAxEchFsipdwjh2aSwCF2PhU6khtrJlOl87tTCk_T57znNzzF2YjB-i2HAzlmH9tTFwsyFdmbOGilSM7rFJ0lyGFaKRhqnc8NYOC0dcQzkJpUfdgOB-wU6KKvNvF-PRN5C5iFlt0Glu_fN3t2EzR5tOPZseO7CUpLuw1s3P0_fgpmFdhRYRRvujB6fuZBQhTnZB0tFOZTwY70Ov-dhrtNy8dIIrTJ6Lq3TgVknAdGCiXEmPcMGZr0ceYyKrLPb1BKpx6nuSIsU9L8GG510oSRVRSuADKKXDNDkCR3qxzwWNFQs8ouEjF6YQrhR6GaWQqHlluJ2NXyRyWnFT3eI9ygiRUWQ6HtmOl-GqkP3IyDR-lDqdqSHKDWocaSBqrtEiqhu8LF5rUzDnGzxNhlMtQxlhesVKcBkOM_UVzegobFZarAx3Vku_tB81wsaLfTr-i_AFrLd63U7UaYdPJ7CBTPi3ab2nUJqMpskZrIrPyWA8Orez9AsMJ-d- |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3rS8MwED90k-EX34_q1IqCKNS1SbolfhubQ3GOMabsW0mTBgbSjT38-03armMogvit0CvX5HKv5PI7gGsZ-iokAjlIVqVDGMcODYXvYCw8KnWIrZI2ne_tWqdDBwPWzWpzzF2YFB8i33AzmpHYa6Pg0ViqyhI1VMRico9NkeY6FInpIlOAYrPXemvnpriGMhhKlzo-wYMcnxRVll-veqRvYeZq1Jq4ndb2P394B7ayeNOupwtkF9aieA9Kr9mJ-j7cNBJjoUmEkf_kwa7bKUiInV6RtLVZmQ6nB9BvPfYbT07WPMERptLFUdp1q8hn2jVRrqRLuODM03OPMZFVFnp6CdU49VxJkeKuG2GD9C6UpIooJfAhFOJRHB2DLd3Q44KGivku0QEkF6YVrhQ6kVJI1FwLbhfzF4gMWNz0t_gIUkhkFJiBB8nALbjKaccpnMaPVOWFGIJMpaaBDkXNRVpENcPL_LVWBnPCweNoNNc0lBGmc1aCLThKxZez0X7Y5FrMgrtESr_wDxqdRi95OvkL8QWUus1W0H7uvJzCJjL-P6nrLUNhNplHZ7AhPmfD6eQ8W6Zfca3oJw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cervical+cancer%3A+A+global+health+crisis&rft.jtitle=Cancer&rft.au=Small%2C+William&rft.au=Bacon%2C+Monica+A&rft.au=Bajaj%2C+Amishi&rft.au=Chuang%2C+Linus+T&rft.date=2017-07-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0008-543X&rft.eissn=1097-0142&rft.volume=123&rft.issue=13&rft.spage=2404&rft_id=info:doi/10.1002%2Fcncr.30667&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-543X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-543X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-543X&client=summon |